CC(=O)O.CCOC(=O)c1c(C)[nH]c2c1c(CN(C)C)c(O)c1nc(C)c(C)nc12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?